Alimta Sales Data
| Rank 43 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Alimta U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 43 ( 3) |
$302,728 | 6.00% | 204 | 7.94% |
| Q3 2013 | 46 ( 4) |
$285,596 | -5.87% | 189 | -5.50% |
| Q2 2013 | 42 (7) |
$303,419 | 10.84% | 200 | 11.73% |
| Q1 2013 | 49 (8) |
$273,747 | -8.17% | 179 | -9.60% |
| Q4 2012 | 41 (6) |
$298,106 | 7.89% | 198 | 8.79% |
| Q3 2012 | 47 (3) |
$276,306 | -1.39% | 182 | -2.67% |
| Q2 2012 | 50 (9) |
$280,190 | 6.53% | 187 | 7.47% |
| Q1 2012 | 59 (1) |
$263,024 | 1.24% | 174 | -0.57% |
| Q4 2011 | 60 (2) |
$259,810 | 1.82% | 175 | 3.55% |
| Q3 2011 | 58 (5) |
$255,178 | 1.37% | 169 | -0.59% |
| Q2 2011 | 63 (4) |
$251,739 | 3.76% | 170 | 4.29% |
| Q1 2011 | 67 | $242,617 | n/a | 163 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.